Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
Open Access
- 16 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
Abstract
Schistosomiasis threatens 800 million people worldwide. Chronic pathology manifests as hepatosplenomegaly, and intestinal schistosomiasis caused by Schistosoma mansoni can lead to liver fibrosis, cirrhosis, and blood in the stool. To assist the only FDA approved drug, praziquantel, in parasite elimination, the development of a vaccine would be of high value. S. mansoni Cathepsin B (SmCB) is a well documented vaccine target for intestinal schistosomiasis. Herein, we test the increased efficacy and immunogenicity of S. mansoni Cathepsin B (SmCB) when combined with sulfated lactosyl archaeol (SLA) archaeosomes or AddaVax™ (a squalene based oil-in-water emulsion). Both vaccine formulations resulted in robust humoral and cell mediated immune responses. Impressively, both formulations were able to reduce parasite burden greater than 40% (WHO standard) with AddaVax™ reaching 86.8%. Additionally, SmCB with both adjuvants were able to reduce granuloma size and the amount of larval parasite hatched from feces which would reduce transmission. Our data support SmCB as a target for S. mansoni vaccination; especially when used in an adjuvanted formulation.Funding Information
- Public Health Agency of Canada
This publication has 45 references indexed in Scilit:
- Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2PLoS Neglected Tropical Diseases, 2012
- Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccineZeitschrift für Parasitenkunde, 2009
- Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armourTrends in Parasitology, 2009
- Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?PLoS Neglected Tropical Diseases, 2008
- RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascadeMolecular and Biochemical Parasitology, 2008
- Current Status of Vaccines for SchistosomiasisClinical Microbiology Reviews, 2008
- Immunity induced by the radiation‐attenuated schistosome vaccineParasite Immunology, 2005
- Role of Gamma Interferon in the Pathogenesis of Severe Schistosomiasis in Interleukin-4-Deficient MiceInfection and Immunity, 2001
- Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice?Immunology Letters, 1999
- SchistosomiasisDigestion, 1998